Aug 18 (Reuters) - Ascelia Pharma AB ACELP.ST :
* WE WILL HAVE TO CONDUCT NEW EVALUATION OF IMAGES WITH
INDEPENDENT READERS BEFORE WE CAN GENERATE RESULTS FROM SPARKLE
STUDY
* ALTHOUGH RE-EVALUATION DOES NOT REQUIRE NEW OR ADDITIONAL
PATIENT RECRUITMENT OR CLINICAL DATA, THIS IS A SETBACK FOR
TIMELINES
* WE WILL COMMUNICATE TIMELINE AND FINANCIAL IMPLICATIONS
FOR THIS
MID-SEPTEMBER
* OUR CONFIDENCE IN POTENTIAL FOR ORVIGLANCE IS UNCHANGED
Source text for Eikon: ID:nMFN3gCBpP
Further company coverage: ACELP.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))